USP1 inhibition induces single strand DNA gap accumulation and overcomes PARP inhibitor resistance in BRCA1 deficient cancer cells

被引：0
|
作者：
da Costa, Alexandre A. B. A.
Somuncu, Ozge
Ravindranathan, Ramya
Mukkavalli, Sirisha
Martignetti, David B.
Nguyen, Huy
Jiao, Yuqing
Lamarre, Benjamin
Moreau, Lisa
Liu, Joyce
Iyer, Divya
Lazaro, Jean-Bernard
Shapiro, Geoffrey I.
Parmar, Kalindi
D'Andrea, Alan D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 01期
关键词：
D O I：
10.1158/1538-7445.DNAREPAIR24-B032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B032
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BRCA1 and BRCA2 deficient cells are sensitive to etoposide-induced DNA double strand breaks via topoisomerase II
    Treszezamsky, A
    Feng, Z
    Junran, Z
    Tokadjian, C
    Kachnic, LA
    Powell, SN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S479 - S480
  • [42] DNA damage response and breast cancer development: Possible therapeutic applications of ATR, ATM, PARP, BRCA1 inhibition
    Mirza-Aghazadeh-Attari, Mohammad
    Recio, Maria Jose
    Darband, Saber Ghazizadeh
    Kaviani, Mojtaba
    Safa, Amin
    Mihanfar, Ainaz
    Sadighparvar, Shirin
    Karimian, Ansar
    Alemi, Forough
    Majidinia, Maryam
    Yousefi, Bahman
    DNA REPAIR, 2021, 98
  • [43] Overcoming immunosuppression and therapeutic resistance to PARP inhibition in BRCA1-deficient breast cancer with STING agonists.
    Wang, Qiwei
    Bergholz, Johann S.
    Ding, Liya
    Lin, Ziying
    Xie, Shaozhen
    Jiang, Tao
    Kim, Hye-Jung
    Roberts, Thomas M.
    Zhao, Jean J.
    CANCER RESEARCH, 2021, 81 (13)
  • [44] TARGETING IMMUNOSUPPRESSIVE MACROPHAGES OVERCOMES PARP-INHIBITOR RESISTANCE IN BRCA1-ASSOCIATED TRIPLE-NEGATIVE BREAST CANCER
    Mehta, Anita
    Cheney, Emily
    Hartl, Christina
    Pantelidou, Constantia
    Oliwa, Madison
    Castrillon, Jessica
    Lin, Jia-Ren
    Hurst, Katie
    Taveira, Mateus De Oliveira
    Johnson, Nathan
    Oldham, William
    Kalocsay, Marian
    Berberich, Matthew
    Boswell, Sarah
    Kothari, Aditi
    Johnson, Shawn
    Dillon, Deborah
    Lipschitz, Mikel
    Rodig, Scott
    Santagata, Sandro
    Garber, Judy
    Tung, Nadine
    Yelamos, Jose
    Thaxton, Jessica
    Mittendorf, Elizabeth
    Sorger, Peter
    Shapiro, Geoffrey
    Guerriero, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A512 - A512
  • [45] OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
    Baquero, Juan Miguel
    Marchena-Perea, Erik
    Mirabet, Rocio
    Torres-Ruiz, Raul
    Blanco-Aparicio, Carmen
    Rodriguez-Perales, Sandra
    Helleday, Thomas
    Benitez-Buelga, Carlos
    Benitez, Javier
    Osorio, Ana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells
    Linglong Yin
    Youhong Liu
    Yuchong Peng
    Yongbo Peng
    Xiaohui Yu
    Yingxue Gao
    Bowen Yuan
    Qianling Zhu
    Tuoyu Cao
    Leye He
    Zhicheng Gong
    Lunquan Sun
    Xuegong Fan
    Xiong Li
    Journal of Experimental & Clinical Cancer Research, 41
  • [47] PLK1 and PARP positively correlate in Middle Eastern breast cancer and their combined inhibition overcomes PARP inhibitor resistance in triple negative breast cancer
    Siraj, Abdul K.
    Poyil, Pratheesh Kumar
    Padmaja, Divya
    Parvathareddy, Sandeep Kumar
    Alobaisi, Khadija
    Thangavel, Saravanan
    Diaz, Roxanne
    Begum, Rafia
    Almalik, Osama
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [48] Discovery of SC10914: a highly potent, selective and orally active PARP inhibitor for the treatment of BRCA1/2 deficient cancer
    Gao, Daxin
    Yang, Heping
    Yu, Yajun
    Kong, Norman
    CANCER RESEARCH, 2015, 75
  • [49] Defining androgen receptor function and the effects of PARP inhibition in BRCA1/2-deficient vs. proficient prostate cancer
    Traphagen, Nicole A.
    Wheeler, Esme
    Li, Rong
    Qiu, Xintao
    Brown, Myles
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Longitudinal analysis of PARP inhibitor and platinum resistance in BRCA1/2m breast cancer using liquid biopsy
    Harvey-Jones, Elizabeth
    Raghunandan, Maya
    Robbez-Masson, Luisa
    Thanussuyah, Alaguthurai
    Liccardo, Roberta
    Yablonovitch, Arielle
    Cai, Mingyang
    Drusbosky, Leylah
    Dorschner, Michael
    Pardo, Lorena Magraner
    Marlow, Rebecca
    Konde, Asha
    Trendell, Jennifer
    Alexander, John
    Haider, Syed
    Starling, Chris
    Roxanis, Ioannis
    Yen, Jennifer
    Pettitt, Stephen J.
    Lord, Christopher J.
    Tutt, Andrew N.
    CANCER RESEARCH, 2023, 83 (07)
12345